- Mainz Biomed (NASDAQ:MYNZ) has priced a follow-on offering of 2M units to raise gross proceeds of approximately $4M.
- Each unit, consisting of one ordinary share (or pre-funded warrant in lieu thereof), one Series A warrant to purchase one ordinary share, and one Series B